COVID-19 Mortality Rates Linked to Active Disease, ICU Deferral in AML, ALL, and MDS - Targeted Oncology
Patients with acute myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndrome had higher mortality rates after being diagnosed with COVID-19 than those with COVID-19 who did not have cancer.
Patients with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplastic syndrome (MDS) had higher mortality rates after being diagnosed with COVID-19 than those with COVID… [+4813 chars]
Read More
Other Stories in Health
- Women remain underserved in cardiovascular disease treatment despite advances
- Junshi Biosciences Announces European Commission Approval for Marketing of Toripalimab
- Through the eyes of a cat – biomimicry of feline eyes may revolutionize robotic vision
- 5 Lessons About Change I Learned from Moving to a New City
- Mpox clade 1b, the strain declared public health emergency by WHO, found in Kerala
- New York resident dies from EEE; state declares virus 'imminent public health threat'
- Pace University ABSN Spring 2025
- Health minister warns retailers still selling illegal vapes could soon face prosecution, months after ban took force
- Stage I vs. Stage IV: A Guide To Understanding Your Breast Cancer From Diagnosis To Treatment
.png)
